Aubrey Rankin, President, Innovation & Technology at Revance Therapeutics, Inc. (RVNC), sold 66,238 shares at $25.95 ($1.7M) on 2021-02-01, disclosed to the SEC on 2021-02-03.
Open-market sale of $1.7M RVNC by President, Innovation & Technology. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.95 | 33,119 | $859K | 50.0% |
| 2 | $25.95 | 33,119 | $859K | 50.0% |
| Total | $25.95 avg | 66,238 | $1.7M | 100% |
| Filing → |
| RVNC | SELL | 2021-07-30 | $1.6M | — | Filing → |
| RVNC | SELL | 2021-07-28 | $3.3M | — | Filing → |
| RVNC | SELL | 2021-04-06 | $57 | — | Filing → |